Physician profile
Jesse Li
NPI 1568415263
$6,461.22
in general payments reported to CMS, 2019-2025
48 companies · $55.42 in 2025
The $55.42 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,610 · 2020: $604 · 2021: $1,427 · 2022: $1,508 · 2023: $1,219 · 2024: $36.99 · 2025: $55.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.81 |
| Education | $273.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $645.16 | 2019-2023 | Briviact |
| Teva Pharmaceuticals USA, INC. | $419.19 | 2019-2023 | Austedo Xr |
| Eisai INC. | $390.25 | 2019-2023 | |
| Abbvie INC. | $371.72 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $360.19 | 2019-2023 | |
| Genzyme Corporation | $353.94 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $347.59 | 2019-2023 | |
| Lilly USA, LLC | $310.76 | 2019-2025 | Emgality, Amyvid, Reyvow |
| Sk Life Science, INC. | $310.32 | 2020-2023 | |
| Amgen INC. | $306.60 | 2019-2022 | |
| Livanova USA, INC. | $263.22 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Allergan, INC. | $255.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $179.89 | 2021-2023 | Ponvory |
| Biogen, INC. | $144.25 | 2019-2022 | |
| Horizon Therapeutics Plc | $138.38 | 2022-2023 | Uplizna |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.